T
HE INFLAMMATORY-CELL and cytokine profiles of allergic chronic sinusitis (CS) are well documented in the literature. Eosinophils, T lymphocytes, and cells expressing T H 2-like cytokines such as interleukin (IL) 4, IL-5, and IL-13 are found in higher numbers in mucosal specimens of atopic patients with CS than in controls. [1] [2] [3] [4] Most patients with cystic fibrosis (CF) develop CS, with 90% to 100% of patients older than 8 months demonstrating radiologic evidence of the disease. 5 The management of CS in patients with CF is often challenging, with many patients having a poor response to standard medical therapies. 6 Although studies have elucidated the pathogenesis of lung disease in patients with CF, [7] [8] [9] [10] [11] [12] [13] [14] little is known about the pathogenesis of sinus disease in these patients. This is primarily because this group represents only a small proportion of the population with CS.
In this study, we investigated whether patients with CF and sinonasal disease have a different pattern of sinus mucosal inflammation than patients with CS and controls. Specifically, we evaluated nasal mucosal specimens from each group of patients for the presence of eosinophils, neutrophils, macrophages, and T lymphocytes, as well for the expression of IL-4, IL-5, IL-8, IL-10, and interferon (IFN) ␥. used as controls. Exclusion criteria included the presence of a known immunodeficiency disorder or use of topical or systemic steroids within 2 weeks prior to surgery. The indications for surgery in these patients were symptomatic CS (congestion, rhinorrhea, olfactory disturbance, facial pain/ headache) for at least 6 months that was unresponsive to standard medical management (antibiotics and/or nasal steroid sprays). All procedures were performed under general anesthesia using an endoscopic approach. Skin testing for perennial and seasonal allergens was done with a standard panel including Alternaria, Aspergillus, Cladosporium, grass, Penicillium, ragweed, trees, cat, cockroach, dog, and dust mites Dermatophagoides farinae and Dermatophagoides pteronyssinus. Histamine (1 mg/mL) was used as a positive control and isotonic sodium chloride as a negative control. A wheal 3 mm or more larger than the negative control was considered a positive skin reaction.
METHODS

PATIENT SELECTION
TISSUE PREPARATION
In preparation for immunohistochemical analysis, biopsy specimens were placed in ornithine carbamoyltransferase (OCT)medium, snap-frozen in liquid nitrogen-cooled isopentane, and stored at −80°C. Cryostat sections were cut 5-µm thick and maintained at −20°C until use for immunohistologic analysis. In preparation for in situ hybridization, the biopsy specimens were immediately fixed in 4% paraformaldehyde for 2 hours. After washing in phosphatebuffered saline with 15% sucrose, they were stored overnight at 4°C. The following day the tissue was blocked in OCT medium and frozen in isopentane cooled in liquid nitrogen. Cryostat sections (10 µm) were then cut from the specimens, placed on poly-L-lysine-coated slides, allowed to dry for 12 hours at 37°C, and stored at −80°C prior to further processing.
IMMUNOHISTOCHEMICAL ANALYSIS
Immunohistochemical analysis was performed using the alkaline phosphatase-anti-alkaline phosphatase method, as previously described. 15 Monoclonal antibodies including anti-CD3, MBP (supplied by R. M. Moqbel, MD, University of Alberta, Edmonton), CD68, and elastase were used to detect T lymphocytes, eosinophils, macrophages, and neutrophils, respectively. Slides were developed using fast red substrate for alkaline phosphatase. A negative control slide was included in each immunohistochemistry experiment.
IN SITU HYBRIDIZATION
Radiolabeled complementary riboprobes (cRNA antisense) for IL-4, IL-5, IL-8, IL-10, and IFN-␥ were used to identify the presence of messenger RNA (mRNA) as previously reported. 16 Cytospins were permeabilized, treated with acetic anhydride and triethanolamine. Sulfur 35 ( 35 S)-labeled antisense probes were used , followed by high-stringency posthybridization washings. Unhybridized single-stranded RNA was removed by treating the preparation with a solution of RNAse. To ensure specificity, sections and cytospins were hybridized with the sense probe or pretreated with an RNAse solution.
QUANTIFICATION
Biopsy specimens were coded, and the number of positive cells for protein and mRNA were counted "blind" using a microscope with an eyepiece graticule at ϫ200 magnification. Results were expressed as the mean ± SEM number of positive cells per square millimeter.
STATISTICAL ANALYSIS
Cell counts were compared among the 3 groups using a MannWhitney test. A P value less than .01 was regarded as statistically significant.
RESULTS
CLINICAL DATA
The mean age of the patients with CF was 32.1 years (range, 22-36 years) vs 39.6 years (range, 30-52 years) in the CS group and 43.5 years (range, 39-53 years) in controls. None of the patients with CF or controls were atopic, whereas 86% of patients with CS had at least 1 positive skin test finding.
IMMUNOHISTOCHEMICAL ANALYSIS
Our immunohistochemical findings are illustrated in Figure 1 . The numbers of neutrophils and macrophages were significantly higher in the nasal mucosa of patients with CF (68.0±2. 6 2 ) (PϽ.01). Although elevated in both groups of patients, the number of T lymphocytes was significantly higher in the CS than in the CF group (PϽ.01).
IN SITU HYBRIDIZATION
Our in situ hybridization findings are illustrated in Studies have consistently demonstrated increased numbers of neutrophils and IL-8-positive cells in bronchoalveolar lavage and sputum samples of patients with CF compared with disease controls. 7, [10] [11] [12] 14 Interleukin 8 is known to be a potent neutrophil chemoattractant and is thought to be critical in the development of the characteristic neutrophil infiltrate in patients with CF. 7 Interleukin 10 is thought to be a potentially important antiinflammatory cytokine in normal lungs, and it is known to suppress IL-8 production. 17 The relative absence of IL-10 in lung specimens of patients with CF has been thought to play an important role in the pathogenesis of this disease in that IL-8 production remains unopposed. 13 We have demonstrated that diseased nasal specimens in patients with CF predominantly consist of neutrophilic infiltrates in the presence of IL-8-positive cells and in the absence of IL-10. Thus, the inflammatory pattern of sinus disease in patients with CF appears to be similar to that found in diseased lung specimens.
In a study assessing the inflammatory profile of nasal lavage specimens in patients with CF without nasal disease and healthy controls, Noah et al 18 found that there was no evidence of neutrophil predominance or increased levels of IL-6, IL-8, or IL-10. Members from this same research group stimulated nasal epithelial cell cultures established from patients with and without CF with TNF-␣ or respiratory syncytial virus and found no difference in the subsequent expression of IL-8. 19 They concluded that the nasal mucosa of patients with CF was not more susceptible than that of patients without the disease to exaggerated inflammatory responses as seen in the bronchial mucosa. Danel et al 20 noted similar results in nasal brush biopsy specimens in adult patients with CF and controls. It is important to note, however, that these studies evaluated the nasal mucosa of patients with CF who had no manifestations of sinonasal disease.
The patients with CS in our study demonstrated mucosal-cell and cytokine profiles consistent with those found in other studies. [1] [2] [3] [4] The number of eosinophils was higher in sinus specimens from this patient group than it was in the CF group and controls. Moreover, the cells expressing T H 2 cytokines, including IL-4, IL-5, and IL-10, were found in higher numbers in patients with CS than in controls. Thus, unlike in the CF group, the inflammatory profile of CS in our atopic patients appears to be mediated by eosinophilic infiltrates in the presence of T H 2-like cytokines.
The observed inflammatory pattern in our CF group may explain the poor response of these patients to topical corticosteroids. Steroid administration is thought to coincide with an alteration in the number and activity of inflammatory cells and with a reduction in the number of T H 2-type cytokines within the nasal mucosa of patients with allergic rhinitis and CS. 2, [21] [22] [23] [24] Aside from directly reducing the synthesis of T H 2-type cytokines, steroids also increase the level of T H 1-type cytokines, particularly IFN-␥ and IL-12, which can suppress the transcription of IL-4. [25] [26] [27] [28] [29] The predominance of neutrophils and paucity of T H 2 cytokines in diseased sinus specimens from patients with CS make the use of topical steroids in these patients questionable. Clinical and molecular studies need to be carried out in this patient group to assess the usefulness of and potential morbidity associated with nasal steroids.
In summary, we have found that the inflammatory pattern of CS in CF is similar to that seen in lower airway specimens, consisting of macrophages and neutrophilic infiltrates in the presence of IFN-␥ and IL-8. The eosinophilic infiltrates and increased expression of T H 2 cytokines characteristic in patients with CS are not found in patients with CF. The different inflammatory pattern seen in diseased sinus specimens of patients with CF may explain the relatively poor response to nasal steroids in this patient group compared with other patients with CS.
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